<html>
<head>PUBMED IDs for LASS5</head>
<body bgcolor='#C5F0F2'><h1>LASS5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16100120/'>LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor.</a> August 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16211262/'>LASS6, an additional member of the longevity assurance gene family.</a> October 8  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16303764/'>The CLN9 protein, a regulator of dihydroceramide synthase.</a> November 24  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16951403/'>Necessary role for the Lag1p motif in (dihydro)ceramide synthase activity.</a> September 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17308067/'>Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas.</a> February 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/28424433/'>[Investigating the role of ceramide metabolism-associated CERS5 (LASS5) gene in atherosclerosis pathogenesis in endothelial cells].</a> April 21  2017<br></body></html>
